Changes in Beneficial Ownership · 4/A
PharmaCyte Biotech, Inc.
PMCBNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4/A
ownership.xml
Amendment · This filing reports the amendment as submitted.
Filing details
- Report period
- 2026-03-31
- Original submission
- 2026-04-02
- Issuer
- PharmaCyte Biotech, Inc.
- Issuer CIK
- 0001157075
- Trading symbol
- PMCB
Reporting owner 1
- Name
- Abecassis Michael M
- Reporting owner CIK
- 0001879281
- Relationship
- Director
- Address
- C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)[F1] | [F1] | 2026-03-31[F1] | J · Form 4[F1] | 0[F1] | A | [F1] | [F1] | [F1] | Common Stock[F1] | [F1] | 0[F1] | D |
Table key
- J · Form 4
- Other acquisition or disposition; see explanation
- A
- Acquired
- D
- Direct
Footnotes
Signature 1
- Signed
- /s/ Michael M. Abecassis
- Date
- 2026-07-17
Company context
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of AssetsNov 19, 2026
- Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other EventsNov 13, 2026
- Changes in Registrant's Certifying AccountantOct 16, 2026
- 10-Q filingSep 14, 2026
- 10-K filingJul 29, 2026